XP-TECH | Health Care Technologies
Life Changing, Life Enhancing.
XP Technology specializes in Health Care technology such as medical devices through its subsidiary ELG-3 Corp and Pharmaceutical products through Pharmico International Corporation.
Learn more
Our Goal
Offer the world a better, safer and painless option in dealing with ailments such as diabetes, and Ketoacidosis; as well as provide meaningful treatment and relief for ALI (Acute lung injury), ARDS (Acute respiratory syndrome), and similar ailments.
Our hopes are that we can achieve our goals by receiving meaningful patent protection based upon our filings, and through our FDA approved clinical trials and as a result be able to successfully commercialize our product developments.
ELG3 Device Technology
The Easy Light Glycometer (ELG) is a Patent Approved (Patent Number 11,089,979) device and method for the measurement of glycated hemoglobin [A1C]. ELG is a non-invasive bloodless testing device that measures both A1C and glucose for Diabetes Mellitus Type 1 and Type 2. The patented ELG is currently undergoing FDA clinical trials, under investigation for use. Learn more about the clinical trial study by visiting https://clinicaltrials.gov keywords: ELG, Diabetes Mellitus.
Our Team
The XP Tech Team consists of physicians, Medical Licensing professionals, FDA legal team and business operations executives.
Pharmico International
Pharmico International Corporation, in corroboration with NIH NIAID Chemical Countermeasures Research Program (CCRP) and the CounterACT Efficacy Research Facility (CERF) is preparing for Phase 1 testing of its patent pending treatment for Acute Lung Injury and Acute Respiratory Distress Syndrome under FDA Emergency Use Authorization (EUA) review. Docket No. ER-00751
